Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT01466179 · COMPLETED
Trial details
- NCT number
- NCT01466179
- Sponsor
- Amgen Research (Munich) GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.